canSAR: An integrated cancer public translational research and drug discovery resource

71Citations
Citations of this article
124Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data. © The Author(s) 2011.

Cite

CITATION STYLE

APA

Halling-Brown, M. D., Bulusu, K. C., Patel, M., Tym, J. E., & Al-Lazikani, B. (2012). canSAR: An integrated cancer public translational research and drug discovery resource. Nucleic Acids Research, 40(D1). https://doi.org/10.1093/nar/gkr881

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free